Previous 10 | Next 10 |
Keego Harbor, Michigan--(Newsfile Corp. - August 11, 2021) - ZIVO Bioscience (NASDAQ: ZIVO) today announced that Andrew Dahl will be attending the Q3 Virtual Investor Summit. About ZIVO Bioscience ZIVO Bioscience, Inc. (NASDAQ: ZIVO), is a biotech/agtech R&D company engag...
KEEGO HARBOR, Mich., July 02, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional product cand...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead Big Tech will be in the spotlight next with the U.S. House Judiciary Committee expected to vote on a package on antitrus...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...
Medley Management (MDLY) +79%.Orbsat Corp (OSAT) +38%.Sphere 3D (ANY) +30%.Xinyuan Real Estate XIN +26% after announcing the completion of five newly constructed properties.Zivo Bioscience (ZIVO) +21%.China HGS Real Estate (HGSH) +18%.Presidio Property Trust (SQFT) +17%.Verona Pharm...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, traders! We’re at it again with another look at the biggest pre-market stock movers for Thursday. It’s worth keeping in mind today that news of a rising inflation rate in April played havoc with...
KEEGO HARBOR, Mich., June 02, 2021 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (NASDAQ:ZIVO), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional bioproduct candidates originally derived from proprietary algal cultur...
KEEGO HARBOR, Mich., June 02, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional product cand...
Zivo Bioscience (ZIVO) has priced its upsized public offering of 2.76M units at $5.00/unit. Each unit consists of one share of common stock and one warrant to purchase one common at an exercise price of $5.50.Expected gross proceeds are $13.8M.Trading kicks off on May 28. Underwriters' over-a...
KEEGO HARBOR, Mich., May 27, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of nutritional/nutraceutical product candidates originally derived from proprietary algal cultures, today announced th...
News, Short Squeeze, Breakout and More Instantly...
ZIVO Bioscience, Inc. (NASDAQ: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces the initiation of a 42-day confirmatory study targeting coccidiosis in collabora...